血糖测试条市场规模、份额、成长分析、按应用、按最终用途、按技术、按地区 - 行业预测，2024-2031 年

2022年全球血糖试纸市场规模将为156亿美元，预测期内（2024-2031年）复合年增长率为8.1%，从2023年的168.6亿美元增加到2031年的314.5亿美元。

根据国际糖尿病联盟称，全球血糖试纸市场对于糖尿病管理至关重要，由于糖尿病盛行率不断上升，该市场正在持续成长，预计到 2045 年糖尿病将影响 7 亿成年人。糖尿病患者数量的快速增加推动了对血糖试纸的需求，这对于有效监测至关重要。此外，向先进血糖监测系统的显着转变，例如连续血糖监测 (CGM) 设备，它提供即时追踪并减少对传统指尖采血测试的依赖。儘管CGM 技术日益普及，但血糖试纸由于其价格实惠且易于使用，仍然是自我监测的首选，并且是传统糖尿病管理解决方案和先进糖尿病管理解决方案的结合，这两种糖尿病管理解决方案仍然是一个强大的市场。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析

血糖测量条市场规模：依应用与复合年增长率（2024-2031）

• 市场概况
• 类型1
• 2型
• 妊娠糖尿病
• 糖尿病前期

血糖测量条市场规模：依最终用途及复合年增长率（2024-2031）

• 市场概况
• 个人
• 医院和诊所
• 其他的

血糖测量条市场规模：依技术及复合年增长率（2024-2031）

• 市场概况
• 葡萄糖脱氢酶（GDH）
• 葡萄糖氧化酵素
• 其他的

按地区分類的血糖测量条市场规模和复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Abbott Laboratories（USA）
• Roche Diagnostics（Switzerland）
• Siemens Healthineers（Germany）
• Thermo Fisher Scientific（USA）
• Danaher Corporation（USA）
• Eurofins Scientific（Luxembourg）
• Qiagen NV（Netherlands）
• Fujifilm Holdings Corporation（Japan）
• DiaSorin SpA（Italy）
• Bio-Rad Laboratories, Inc.（USA）
• Sekisui Medical Corporation（Japan）
• Ortho Clinical Diagnostics（USA）
• Beckman Coulter, Inc.（USA）
• Myriad Genetics, Inc.（USA）
• Alere Inc.（USA）
• Quest Diagnostics Incorporated（USA）
• LabCorp（USA）
• BioMerieux SA（France）
• ARUP Laboratories（USA）
• MSD（Merck & Co., Inc.）（USA）

结论和建议

Global Blood Glucose Test Strips Market size was valued at USD 15.6 billion in 2022 and is poised to grow from USD 16.86 billion in 2023 to USD 31.45 billion by 2031, growing at a CAGR of 8.1% during the forecast period (2024-2031).

The global blood glucose test strips market is essential to diabetes management, experiencing consistent growth due to the rising prevalence of diabetes, projected to affect 700 million adults by 2045, according to the International Diabetes Federation. This surge in diabetes cases drives demand for blood glucose test strips, vital for effective monitoring. Additionally, there's a notable shift toward advanced glucose monitoring systems like continuous glucose monitoring (CGM) devices, which offer real-time tracking and reduce the reliance on traditional fingerstick testing. Despite the increasing popularity of CGM technologies, blood glucose test strips remain the preferred choice for self-monitoring due to their affordability and ease of use, indicating a continued strong market for both traditional and advanced diabetes management solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blood Glucose Test Strips market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Blood Glucose Test Strips Market Segmental Analysis

Global Blood Glucose Test Strips Market is segmented by Application, End Use, Technology and Region. Based on Application, the market is segmented into diabetes. Based on End Use, the market is segmented into individuals, hospitals and clinics and others. Based on Technology, the market is segmented into glucose dehydrogenase (GDH), glucose oxidase and others. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Blood Glucose Test Strips Market

The blood glucose test strips market is experiencing significant growth, driven by heightened awareness of the importance of diabetes management and increased healthcare spending. As both governments and healthcare organizations globally prioritize early detection and effective treatment of diabetes, there is a corresponding rise in the adoption of glucose monitoring devices. This focus on improving patient outcomes has led to a surge in demand for blood glucose test strips, as individuals and healthcare providers alike recognize their essential role in managing diabetes effectively. Overall, this combination of awareness and investment in healthcare is propelling the market forward.

Restraints in the Global Blood Glucose Test Strips Market

The Global Blood Glucose Test Strips market faces significant challenges due to the rise of alternative monitoring methods, particularly continuous glucose monitoring (CGM) systems. These advanced technologies provide users with real-time glucose readings, minimizing the need for frequent fingerstick tests and enhancing convenience in monitoring blood sugar levels. As more patients and healthcare providers recognize the benefits of CGM systems, the demand for traditional blood glucose test strips may decline. Consequently, this shift towards more sophisticated and comprehensive glucose monitoring solutions could severely impact the market's growth and profitability, posing a notable restraint for blood glucose test strips manufacturers.

Market Trends of the Global Blood Glucose Test Strips Market

The global blood glucose test strips market is experiencing a notable shift towards continuous glucose monitoring (CGM) systems, driven by increasing consumer demand for efficient and convenient glucose management solutions. With advancements in sensor technology, CGMs allow for real-time tracking of blood glucose levels, significantly reducing the reliance on traditional fingerstick tests. This trend is further fueled by rising awareness among diabetes patients regarding the benefits of continuous monitoring, such as enhanced accuracy and the ability to make timely health decisions. As a result, manufacturers are innovating to integrate CGM capabilities, positioning themselves to cater to the evolving preferences of health-conscious consumers.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Blood Glucose Test Strips Market Size by Application & CAGR (2024-2031)

• Market Overview
• Type 1
• Type 2
• Gestational Diabetes
• Pre-Diabetes

Global Blood Glucose Test Strips Market Size by End Use & CAGR (2024-2031)

• Market Overview
• Individuals
• Hospitals and Clinics
• Others

Global Blood Glucose Test Strips Market Size by Technology & CAGR (2024-2031)

• Market Overview
• Glucose Dehydrogenase (GDH)
• Glucose Oxidase
• Others

Global Blood Glucose Test Strips Market Size & CAGR (2024-2031)

• North America (Application, End Use, Technology)
  • USA
  • Canada
• Europe (Application, End Use, Technology)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Application, End Use, Technology)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Application, End Use, Technology)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Application, End Use, Technology)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui Medical Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alere Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LabCorp (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARUP Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MSD (Merck & Co., Inc.) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations